Bafilomycin B1

Star0

DB06734ExperimentalSmall molecule

Bafilomycin B1: Overview.

Mechanism: Pharmacologically active on V-type proton ATPase catalytic subunit A
Curator reviewed
Formula / weight: C₄₄H₆₅NO₁₃ · 815.998 g/mol (avg)
Also known as: Setamycin

Resolves to

Compound

CAS88899-56-3

Structure

InChIKeyKFUFLYSBMNNJTF-MZYUNMTESA-NSMILES

CO[C@H]1\C=C/C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(\C)/C=C(OC)\C(=O)OC1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](OC(=O)\C=C\C(=O)NC2=C(O)CCC2=O)[C@H](C)[C@H](O1)C(C)C

Targets

P38606ATP6V1A

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Bafilomycin B1, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account